BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7646921)

  • 1. Fluorescence polarisation changes in lymphocyte cytoplasm as a diagnostic test for breast carcinoma.
    Ron IG; Deutsch M; Tirosh R; Weinreb A; Eisenthal A; Chaitchik S
    Eur J Cancer; 1995 Jun; 31A(6):917-20. PubMed ID: 7646921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An approach for high sensitivity detection of prostate cancer by analysis of changes in structuredness of the cytoplasmic matrix of lymphocytes specifically induced by PSA-ACT.
    Klein O; Lin S; Embon O; Sazbon A; Zidan J; Kook AI
    J Urol; 1999 Jun; 161(6):1994-6. PubMed ID: 10332488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour specificity of the SCM test for cancer diagnosis.
    Chaitchik S; Asher O; Deutsch M; Weinreb A
    Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1165-70. PubMed ID: 2416568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical assessment of fluorescence polarisation changes in lymphocytes stimulated by phytohaemagglutinin (PHA) in malignant and benign diseases.
    Pritchard JA; Sutherland WH; Siddall JE; Bater AJ; Kerby IJ; Deeley TJ; Griffith G; Sinclair R; Davies BH; Rimmer A; Webster DJ
    Eur J Cancer Clin Oncol; 1982 Jul; 18(7):651-9. PubMed ID: 6751831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of the SCM test for the diagnosis of cancer of the breast.
    Chaitchik S; Deutsch M; Asher O; Krauss G; Lebovich P; Michlin H; Weinreb A
    Eur J Cancer Clin Oncol; 1988 May; 24(5):861-6. PubMed ID: 3169091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of melanoma by monitoring the intracellular fluorescein fluorescence polarization changes in lymphocytes.
    Merimsky O; Kaplan B; Deutsch M; Tirosh R; Weinreb A; Chaitchik S
    Cancer Detect Prev; 1997; 21(2):167-77. PubMed ID: 9101078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Response of human lymphocytes to phytohemagglutinin (PHA) as measured by fluorescence polarization technique--differences between malignant conditions and benign or healthy conditions].
    Tenzaki T; Ishiguro T
    Nihon Gan Chiryo Gakkai Shi; 1989 Apr; 24(4):817-25. PubMed ID: 2778375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New SCM (structuredness of the cytoplasmatic matrix)-based approach in breast cancer detection.
    Birindelli S; Colnaghi MI; Pilotti S
    Tumori; 1996; 82(6):550-3. PubMed ID: 9061062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptation of the cellscan technique for the SCM test in breast cancer.
    Rahmani H; Deutsch M; Ron I; Gerbat S; Tirosh R; Weinreb A; Chaitchik S; Lalchuk S
    Eur J Cancer; 1996 Sep; 32A(10):1758-65. PubMed ID: 8983287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in structuredness of cytoplasmic matrix in single stimulated lymphocytes from healthy donors and patients with non-malignant and malignant diseases.
    Hashimoto Y; Takaku F; Yamanaka T
    Br J Cancer; 1979 Jul; 40(1):156-60. PubMed ID: 454560
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer-specific density changes in lymphocytes after stimulation with phytohaemagglutinin.
    Pritchard JA; Sutherland WH; Seaman JE; Deeley TJ; Evans IH; Kerby IJ; James KW; Paterson IC
    Lancet; 1978 Dec; 2(8103):1275-7. PubMed ID: 82780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of T lymphocytes to phytohaemagglutinin (PHA) and to cancer-tissue-associated antigens, measured by the intracellular fluorescence polarization technique (SCM test).
    Orjasaeter H; Jordfald G; Svendsen I
    Br J Cancer; 1979 Oct; 40(4):628-33. PubMed ID: 387060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of colon cancer by monitoring the intracellular fluorescein fluorescence polarization changes in lymphocytes.
    Merimsky O; Duetsch M; Tirosh R; Wohl I; Weinreb A; Chaitchik S
    Cancer Detect Prev; 1996; 20(4):300-7. PubMed ID: 8818390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study.
    Wiltschke C; Krainer M; Budinsky AC; Berger A; Müller C; Zeillinger R; Speiser P; Kubista E; Eibl M; Zielinski CC
    Br J Cancer; 1995 Jun; 71(6):1292-6. PubMed ID: 7779726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the SCM response ratio (RRscm) after surgical removal of malignant tissue.
    Cercek L; Cercek B
    Br J Cancer; 1975 Feb; 31(2):250-1. PubMed ID: 1164472
    [No Abstract]   [Full Text] [Related]  

  • 16. Response of human lymphocytes to PHA and tumour-associated antigens as detected by fluorescence polarization.
    Balding P; Light PA; Preece AW
    Br J Cancer; 1980 Jan; 41(1):73-85. PubMed ID: 6153900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine-needle aspiration of clinically suspicious palpable breast masses with histopathologic correlation.
    Ariga R; Bloom K; Reddy VB; Kluskens L; Francescatti D; Dowlat K; Siziopikou P; Gattuso P
    Am J Surg; 2002 Nov; 184(5):410-3. PubMed ID: 12433603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte fluorescence polarization measurements with the cellscan system: application to the SCM cancer test.
    Deutsch M; Ron I; Weinreb A; Tirosh R; Chaitchik S
    Cytometry; 1996 Feb; 23(2):159-65. PubMed ID: 8742175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biophysical differentiation between lymphocytes from healthy donors, patients with malignant diseases and other disorders.
    Cercek L; Cercek B; Franklin CI
    Br J Cancer; 1974 May; 29(5):345-52. PubMed ID: 4136566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of lymphocyte membrane fluidity in rheumatoid arthritis: a fluorescence polarisation study.
    Beccerica E; Piergiacomi G; Curatola G; Ferretti G
    Ann Rheum Dis; 1988 Jun; 47(6):472-7. PubMed ID: 3382266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.